NIH-funded research R01 grant

Exploring a new molecule for anesthesia

Official title: Discovery and Development of a Benzoquinone Molecule as a Novel Anesthetic

Funded at Columbia University Health Sciences · NIH-10910165 · Data updated 2026-11-12

This study is looking at a new type of anesthetic that could help people go to sleep safely during surgery while also reducing memory loss and side effects, making the whole experience better for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2027
Funding year2024
Award (this year)$463,770
NIH project number5R01GM148716-02
Project IDNIH-10910165 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals undergoing surgical procedures who require anesthesia and may be at risk for adverse effects from current anesthetic agents.

Less likely to help

Patients who are not undergoing surgery or do not require anesthesia will likely not benefit from this research.

What this research studies

This research investigates a novel anesthetic molecule, specifically a synthetic CoQ analog from the 1,4-benzoquinone class, to understand its effects on inducing unconsciousness and preventing memory loss during anesthesia. The study aims to characterize how this molecule interacts with mitochondrial function, which is crucial for its anesthetic properties. By examining the mechanisms of action, the research seeks to develop safer anesthetic options that minimize adverse effects commonly associated with current sedative-hypnotics. Patients may benefit from improved anesthesia experiences with fewer side effects if successful.

Why it matters

Potential benefit: If successful, this research could lead to the development of a safer anesthetic that reduces adverse effects and improves patient outcomes during surgical procedures.

How similar studies have gone: While the approach of using 1,4-benzoquinones as anesthetics is novel, previous studies have shown promise in understanding anesthetic mechanisms, indicating potential for success.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Levy, Richard J — Columbia University Health Sciences
  • Study coordinator: Levy, Richard J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.